The Board proposes the rule amendment to add additional drugs to the rule.  


  • RULE NO: RULE TITLE
    64B16-28.850: Special Pharmacy - ESRD
    PURPOSE AND EFFECT: The Board proposes the rule amendment to add additional drugs to the rule.
    SUMMARY: Additional drugs will be listed in the rule.
    SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared.
    Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
    SPECIFIC AUTHORITY: 465.005, 465.0125 FS.
    LAW IMPLEMENTED: 465.0196, 465.022 FS.
    IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca R. Poston, Executive Director, Board of Pharmacy/MQA, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3253

    THE FULL TEXT OF THE PROPOSED RULE IS:

    64B16-28.850 Special Pharmacy – ESRD.

    (1) through (2) No change.

    (3) Schedule of legend drugs:

    (a) Saline Solutions.

    (b) Porcine Heparin.

    (c) Beef Heparin.

    (d) Dextrose Solutions.

    (e) Doxercalciferol.

    (f) Epoetin Alfa.

    (g)(e) NACL INJ 50 MEQ/20 ML.

    (h) Levocarnitine.

    (i)(f) Lidocaine.

    (j)(g) Vitamin Preparations (dialysate use only).

    (k) Paricalcitrol.

    (l)(h) Peritoneal Dialysate Solutions.

    (m)(i) Protamine Sulfate.

    (n)(j) Potassium 20 MEQ/10ML (dialysate use only).

    (o) Sodium Ferric Gluconate Complex or equivalent.

    (p)(k) Sterile Water for Irrigation.

    (4) through (17) No change.

    Specific Authority 465.005, 465.0125 FS. Law Implemented 465.0196, 465.022 FS. History–New 10-2-94, Formerly 59X-28.850, Amended 9-20-99, 7-17-05,__________.


    NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Pharmacy
    NAME OF SUPERVISOR OR PERSON WHO APPROVED THE PROPOSED RULE: Board of Pharmacy
    DATE PROPOSED RULE APPROVED BY AGENCY HEAD: February 5, 2008
    DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAW: March 21, 2008

Document Information

Comments Open:
5/2/2008
Summary:
Additional drugs will be listed in the rule.
Purpose:
The Board proposes the rule amendment to add additional drugs to the rule.
Rulemaking Authority:
465.005, 465.0125 FS.
Law:
465.0196, 465.022 FS.
Contact:
Rebecca R. Poston, Executive Director, Board of Pharmacy/MQA, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3253
Related Rules: (1)
64B16-28.850. Special Pharmacy - ESRD